Skip to main content
. 2013 Dec;3(4):926–935. doi: 10.1086/674755

Table 3.

Top five networks in sham-operated C57BL/6 mice that were treated with GW0742

Associated network functions Molecules in network Focus molecules Score
Cell cycle, cellular development, cellular growth and proliferation BMP4, CCNA1, CCNE1, CCNE2, CDC25A, CDK2, CDKN1A, CDX2, CHEK1, CSF1 (includes EG:12977), CUL1, cyclin A, cyclin E, ELAVL1, FOXM1, HDAC3, HDAC4, histone H1, KLF4, LGALS1, MAP2K1, NCOR1, NCOR2, NPM1, OSM, PCNA, POLR2A, PRKCE, PYHIN1, RBL2 (includes EG:100331892), SFN, SKP2 (includes EG:27401), SP3, TOPBP1, TSPYL2 2 3
Amino acid metabolism, small-molecule biochemistry, connective tissue disorders PPAT, SREBF1 1 3
Amino acid metabolism, auditory and vestibular system development and function, cellular development DIO2, MARCH6 1 3
Cell death, protein synthesis, cellular development DGAT2, ERN1 1 3
Developmental disorder, genetic disorder, metabolic disease CTSD, HEXB, MREG 1 3
Note

Animals underwent a sham operation and after several days were orally dosed with vehicle or GW0742 (30 mg/kg). After 14 days, the right ventricle was excised, and RNA was extracted from each sample. Gene expression was measured using the Illumina MouseRef-8v3 BeadChip array, and data were analyzed using the syntax package R (ver. 2.3.1) with Bioconductor and limma. Genes that were significantly modified, as calculated using a moderated t test followed by Benjamini-Hochberg false-discovery rate correction, were imported into Ingenuity Pathway Analysis software. The table shows the top five networks identified from genes differentially expressed in C57BL/6 mice treated with GW0742 compared with sham-operated controls.